Pairing glutathione with a prebiotic like Performance Lab Prebiotic may further benefit digestive balance
Researchers said the effectiveness of a once-weekly dose of semaglutide to treat type 2 diabetes has been demonstrated in randomised controlled trials, but long-term data has been lacking
Understanding common mistakes and implementing preventive strategies is essential for patient safety
Tirzepatide deep-dive Tirzepatide is made by Eli Lilly under two brand names: Mounjaro -- weekly injection, FDA-approved for type 2 diabetes in 2022 (doses 2.5 mg through 15 mg) Zepbound -- weekly injection, FDA-approved for chronic weight management in November 2023 [4] The headline trial is SURMOUNT-1: 2,539 adults without diabetes, BMI of 30 or higher (or 27 with a weight-related condition), randomized across three tirzepatide doses (5, 10, 15 mg) versus placebo for 72 weeks
That means it may still be some time before patients can access it outside of a trial setting
GLP-1 drugs can cause nausea and vomiting in some people, which increases the risk of dehydration